Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for pH Adjustment During Ointment Development – V 2.0

Posted on By

SOP for pH Adjustment During Ointment Development – V 2.0

Procedure for pH Adjustment During Ointment Development

Department Research and Development (R&D)/Quality Control
SOP No. FD-017
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a systematic approach for adjusting and controlling the pH of ointments during formulation development. Proper pH balance ensures product stability, efficacy, and skin compatibility.

2. Scope

This SOP applies to the Research and Development (R&D) and Quality Control (QC) departments responsible for monitoring and adjusting the pH of ointments during formulation trials and manufacturing scale-up.

3. Responsibilities

  • Formulation Scientist: Adjusts and optimizes pH levels during formulation development.
  • Quality Control (QC) Analyst: Conducts pH testing and verifies compliance with specifications.
  • Quality Assurance (QA) Personnel: Ensures compliance with standard procedures and regulatory guidelines.
  • R&D Head: Reviews and approves pH adjustment reports before finalizing formulations.
See also  Ointments: SOP for Formulation Development of Ointments - V 2.0

4. Accountability

The R&D and QC Managers are accountable for ensuring that pH adjustment is conducted per regulatory and quality standards.

5. Procedure

5.1 Selection of pH Range

  • Determine the optimal pH range for the ointment based on:
    • Skin compatibility (typically 4.5 – 7.0)
    • API stability requirements
    • Preservative efficacy
  • Ensure that the target pH range is specified in the formulation protocol.

5.2 Preparation of Sample for pH Measurement

  • Weigh 1 g of the ointment sample.
  • Disperse in 10 mL of distilled water or a suitable solvent.
  • Stir for 5 minutes using a magnetic stirrer.
  • Allow the sample to equilibrate at room temperature (25°C ± 2°C).

5.3 pH Measurement

  • Calibrate the pH meter using standard buffer solutions (pH 4.0, 7.0, and 10.0).
  • Immerse the pH electrode into the sample solution.
  • Record the pH reading once it stabilizes.
  • Rinse the electrode with distilled water after each measurement.

5.4 Adjustment of pH

  • If pH is lower than the target range:
    • Add a small amount (0.1 – 1.0% w/w) of a suitable alkaline agent (e.g., sodium hydroxide, triethanolamine).
    • Mix thoroughly and recheck the pH.
    • Repeat until the pH reaches the desired range.
  • If pH is higher than the target range:
    • Add a small amount (0.1 – 1.0% w/w) of an acidic agent (e.g., citric acid, lactic acid).
    • Mix thoroughly and recheck the pH.
    • Repeat until the pH reaches the desired range.
See also  Ointments: SOP for Ensuring Accuracy in Weighing Raw Materials - V 2.0

5.5 Confirmation and Stability Testing

  • Confirm the final pH by measuring triplicate samples.
  • Store samples at different stability conditions:
    • 25°C ± 2°C / 60% RH
    • 40°C ± 2°C / 75% RH
    • Refrigerated conditions (2-8°C)
  • Monitor pH over a period of time to ensure stability.

5.6 Documentation and Reporting

  • Record all pH test results in the pH Adjustment Log.
  • Summarize findings in the pH Adjustment Report.
  • Obtain approval from the R&D Head and QA before finalizing pH parameters.

6. Abbreviations

  • QC – Quality Control
  • QA – Quality Assurance
  • RH – Relative Humidity
  • USP – United States Pharmacopeia
  • BP – British Pharmacopeia
  • IP – Indian Pharmacopeia
See also  Ointments: SOP for Line Clearance Before Production - V 2.0

7. Documents

  • pH Adjustment Log (Annexure-1)
  • pH Adjustment Report (Annexure-2)

8. References

  • USP <791> pH Measurement Guidelines
  • ICH Q1A (R2) Stability Testing Guidelines
  • WHO GMP Guidelines for Pharmaceutical Manufacturing
  • 21 CFR Part 211 – Current Good Manufacturing Practices

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: pH Adjustment Log

Date Batch Number Initial pH Adjustment Agent Final pH Verified By
01/02/2025 OINT-001 4.2 Triethanolamine 5.5 QA Officer
02/02/2025 OINT-002 7.8 Citric Acid 6.8 QA Officer

Annexure-2: pH Adjustment Report

Date Batch Number Initial pH Target pH Final pH Final Status
01/02/2025 OINT-001 4.2 5.5-7.0 5.5 Pass
02/02/2025 OINT-002 7.8 5.5-7.0 6.8 Pass

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: SOP for Incineration of Pharmaceutical Waste
Next Post: SOP for Documentation of Waste Management Activities

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version